BR9914835A - Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem - Google Patents

Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem

Info

Publication number
BR9914835A
BR9914835A BR9914835-8A BR9914835A BR9914835A BR 9914835 A BR9914835 A BR 9914835A BR 9914835 A BR9914835 A BR 9914835A BR 9914835 A BR9914835 A BR 9914835A
Authority
BR
Brazil
Prior art keywords
protein
salts
screening
peptide
kit
Prior art date
Application number
BR9914835-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Takuya Watanabe
Yasuko Terao
Yasushi Shintani
Tetsuya Ohtaki
Kimiko Kanehashi
Chieko Kitada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BR9914835A publication Critical patent/BR9914835A/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
BR9914835-8A 1998-10-27 1999-10-26 Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem BR9914835A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30594998 1998-10-27
JP2771099 1999-02-04
JP5720799 1999-03-04
JP27622599A JP4486187B2 (ja) 1998-10-27 1999-09-29 新規g蛋白質共役型レセプター蛋白質、そのdnaおよびそのリガンド
PCT/JP1999/005905 WO2000024890A1 (en) 1998-10-27 1999-10-26 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same

Publications (1)

Publication Number Publication Date
BR9914835A true BR9914835A (pt) 2002-06-18

Family

ID=27458743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914835-8A BR9914835A (pt) 1998-10-27 1999-10-26 Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem

Country Status (19)

Country Link
US (3) US6699965B1 (enExample)
EP (1) EP1126028B1 (enExample)
JP (1) JP4486187B2 (enExample)
KR (1) KR20010085974A (enExample)
CN (1) CN1324405A (enExample)
AT (1) ATE394485T1 (enExample)
AU (1) AU6230699A (enExample)
BR (1) BR9914835A (enExample)
CA (1) CA2347294A1 (enExample)
CZ (1) CZ20011358A3 (enExample)
DE (1) DE69938666D1 (enExample)
HU (1) HUP0104937A2 (enExample)
ID (1) ID28288A (enExample)
IL (1) IL142428A0 (enExample)
NO (1) NO20012059L (enExample)
NZ (1) NZ510977A (enExample)
PL (1) PL347553A1 (enExample)
SK (1) SK5502001A3 (enExample)
WO (1) WO2000024890A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536989A (ja) * 1999-02-24 2002-11-05 メルク エンド カムパニー インコーポレーテッド ガラニン受容体と類似したgタンパク質共役受容体
EP1273658A4 (en) * 2000-03-30 2004-08-11 Takeda Chemical Industries Ltd NEW PROTEIN, THEIR DNA AND METHOD FOR THE PRODUCTION THEREOF
EP1168259A3 (en) 2000-06-28 2003-12-17 Hitachi, Ltd. Data management method and system for IC card
AU8020201A (en) * 2000-08-30 2002-03-13 Wakenyaku Co Ltd Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same
JP2002109169A (ja) 2000-09-29 2002-04-12 Hitachi Ltd 作業支援方法並びにシステム及び作業支援方法を記録した記録媒体
ATE416784T1 (de) 2000-12-01 2008-12-15 Takeda Pharmaceutical Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
WO2002059344A2 (en) * 2000-12-18 2002-08-01 Merck & Co., Inc. Gpr54 g protein-coupled receptor
WO2002057309A1 (fr) * 2001-01-18 2002-07-25 Takeda Chemical Industries, Ltd. Nouvelle proteine receptrice couplee a la proteine g et adn de cette proteine
WO2002072816A1 (fr) * 2001-02-26 2002-09-19 Takeda Chemical Industries, Ltd. Proteine de recepteur murin de type kiss-1 et adn correspondant
WO2002083735A1 (fr) * 2001-04-06 2002-10-24 Takeda Chemical Industries, Ltd. Nouvelle proteine receptrice et son adn
AU2008201995A1 (en) * 2001-09-18 2008-05-29 Genentech, Inc. Compositions and methods for the diagnosis and treament of tumor
KR101008758B1 (ko) 2001-09-18 2011-01-14 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
CA2460803A1 (en) 2001-09-19 2003-04-03 Takeda Chemical Industries, Ltd. Antibody against metastin and use thereof in diagnosing pregnancy
AU2003201854A1 (en) * 2002-01-11 2003-07-30 Takeda Chemical Industries, Ltd. PROCESS FOR PRODUCING KiSS-1 PEPTIDE
JP2006521082A (ja) * 2002-09-11 2006-09-21 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための新規組成物と方法
US20060241051A1 (en) 2002-12-26 2006-10-26 Chieko Kitada Metastin derivatives and use thereof
US6800611B2 (en) * 2003-01-06 2004-10-05 Takeda Chemical Industries, Ltd. Metastin derivatives and their use
CA2518541C (en) * 2003-03-12 2013-05-21 Takeda Pharmaceutical Company Limited Gonadal function improving agents
JP4639052B2 (ja) * 2003-03-12 2011-02-23 武田薬品工業株式会社 性腺機能改善剤
EP1464652A1 (en) * 2003-04-02 2004-10-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases
AU2004234399A1 (en) * 2003-04-28 2004-11-11 Wyeth Methods utilising G-protein coupled receptor 54
WO2004101747A2 (en) * 2003-05-07 2004-11-25 The General Hospital Corporation Identification and use of gpr54 and its ligands for reproductive disorders and contraception
WO2005040833A1 (en) * 2003-10-21 2005-05-06 Bayer Healthcare Ag Regulation of human metastin recognising receptors
JP4346650B2 (ja) 2004-06-25 2009-10-21 武田薬品工業株式会社 メタスチン誘導体およびその用途
AR058584A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US20090099334A1 (en) * 2005-12-22 2009-04-16 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
ITMI20061607A1 (it) 2006-08-09 2008-02-10 Maria Vincenza Carriero Peptidi con attivita farmacologica
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
JPWO2009131191A1 (ja) * 2008-04-24 2011-08-25 武田薬品工業株式会社 メタスチン誘導体およびその用途
WO2010013762A1 (ja) 2008-07-30 2010-02-04 武田薬品工業株式会社 メタスチン誘導体およびその用途
MX2011003117A (es) * 2008-09-19 2011-04-21 Nektar Therapeutics Conjugados polimericos de peptidos terapeuticos.
EP2340047A1 (en) * 2008-09-19 2011-07-06 Nektar Therapeutics Polymer conjugates of kiss1 peptides
WO2010137022A1 (en) 2009-05-27 2010-12-02 Yeda Research And Development Co. Ltd Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
EP2873422A4 (en) 2012-07-10 2015-12-30 Takeda Pharmaceutical PHARMACEUTICAL PREPARATION FOR INJECTION
CN109206481B (zh) 2017-07-05 2023-08-18 尚华医药科技(江西)有限公司 一种肽类化合物、其应用及含其的组合物
CN109212217B (zh) * 2018-11-07 2021-09-10 李玉民 基于amy1a蛋白胃癌检测试剂盒及其使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436155A (en) * 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
EP0804575A1 (en) 1994-08-11 1997-11-05 Takeda Chemical Industries, Ltd. G protein coupled receptor protein, production, and use thereof
WO1997013778A1 (en) 1995-10-11 1997-04-17 The Penn State Research Foundation A metastasis suppressor gene
US6010877A (en) * 1997-01-10 2000-01-04 Smithkline Beecham Corporation cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor
US5851798A (en) * 1997-01-27 1998-12-22 Smithkline Beecham Corporation Nucleic acid encoding human GPR14 receptor
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
CA2283299A1 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
JP2002536989A (ja) * 1999-02-24 2002-11-05 メルク エンド カムパニー インコーポレーテッド ガラニン受容体と類似したgタンパク質共役受容体
US20020077469A1 (en) * 1999-03-10 2002-06-20 Borowsky Beth E. DNA encoding orphan SNORF11 receptor
CA2518541C (en) * 2003-03-12 2013-05-21 Takeda Pharmaceutical Company Limited Gonadal function improving agents

Also Published As

Publication number Publication date
JP4486187B2 (ja) 2010-06-23
ATE394485T1 (de) 2008-05-15
CN1324405A (zh) 2001-11-28
PL347553A1 (en) 2002-04-08
HUP0104937A2 (hu) 2002-04-29
US20080131976A1 (en) 2008-06-05
EP1126028B1 (en) 2008-05-07
US20040180407A1 (en) 2004-09-16
IL142428A0 (en) 2002-03-10
EP1126028A4 (en) 2002-11-27
US6699965B1 (en) 2004-03-02
ID28288A (id) 2001-05-10
AU6230699A (en) 2000-05-15
US7608409B2 (en) 2009-10-27
WO2000024890A1 (en) 2000-05-04
NO20012059D0 (no) 2001-04-26
DE69938666D1 (de) 2008-06-19
CA2347294A1 (en) 2000-05-04
JP2000312590A (ja) 2000-11-14
US7314754B2 (en) 2008-01-01
NO20012059L (no) 2001-06-26
NZ510977A (en) 2002-10-25
KR20010085974A (ko) 2001-09-07
SK5502001A3 (en) 2002-01-07
EP1126028A1 (en) 2001-08-22
CZ20011358A3 (cs) 2001-08-15

Similar Documents

Publication Publication Date Title
BR9914835A (pt) Proteìna e seus sais, método para fabricar a mesma, anticorpo para a mesma, ligando à mesma, método para determinar o mesmo, peptìdeo parcial da proteìna ou seus ésteres ou suas amidas ou seus sais, polinucleotìdeo, vetor recombinante, transformante, composição de diagnóstico, composição farmacêutica, composto ou seus sais, método para triar o mesmo, kit para triar o mesmo, método para quantificar a proteìna, peptìdeo, uma amida deste, um éster deste ou um sal deste, amida ou sal do peptìdeo, método para triagem, e, kit para filtragem
Davletov et al. Isolation and biochemical characterization of a Ca2+-independent α-latrotoxin-binding protein
DE69231473T2 (de) Immunochemischer nachweiss von endprodukten der fortgeschrittenen glycosylation in vivo
DE3650080T2 (de) Verfahren und Mittel zur Hemmung des Proteinveraltens.
Hirn et al. Molecular heterogeneity and structural evolution during cerebellar ontogeny detected by monoclonal antibody of the mouse cell surface antigen BSP-2
JP5270337B2 (ja) 抗Aβ抗体を精製する方法
DE10303974A1 (de) Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
DE69113273T2 (de) Zellnekrosnachweis durch prüfung von spektrin und seine abbauprodukte.
AT500379A2 (de) Tau-proteine
ATE131471T1 (de) An fette gebundene aminosäuren, peptide oder deren derivate
Schroeder et al. The amino acid composition of certain morphologically distinct parts of white turkey feathers, and of goose feather barbs and goose down
Trüeb et al. Nonenzymatic glycosylation of basement membrane collagen in diabetes mellitus
DE3751316T2 (de) Materialzusammensetzung, welche ein Polypeptid aus Pankreas-Insel-Amyloid und/oder Antikörpern gegen dieses Polypeptid enthält, und Anwendung dieser Zusammensetzung.
EP1353948B1 (de) Lösliche cyclische analoga des beta amyloiden peptids
Ringvold A preliminary report on the amino acid composition of the pseudo-exfoliation material (PE material)
EP0124896B1 (de) Verfahren zur Gewinnung von Viren bzw. Virusantigenen und deren Anwendung in Diagnose und Therapie (Impfstoff)
Aster et al. The 4.1-like proteins of the bovine lens: spectrin-binding proteins closely related in structure to red blood cell protein 4.1.
BAERT et al. Yolk protein in leech: identification, purification and characterization of vitellin and vitellogenin
DE60120782T2 (de) Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung
DE10230141A1 (de) Verfahren zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
DE69316388T2 (de) CRF Bindungsproteine
Veis Phosphoproteins from teeth and bone
Wilkinson et al. Localization of rabbit huntingtin using a new panel of monoclonal antibodies
Cohen et al. Synthesis of 5-hydroxypipecolic acid and separation of its diastereoisomers
DE69233673T2 (de) Protein S polypeptide und deren Verwendungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.